0001415889-24-013146.txt : 20240514 0001415889-24-013146.hdr.sgml : 20240514 20240514173513 ACCESSION NUMBER: 0001415889-24-013146 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240510 FILED AS OF DATE: 20240514 DATE AS OF CHANGE: 20240514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Funck, Jr. Robert E. CENTRAL INDEX KEY: 0001565892 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 24946014 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: D-378, AP6D-2 CITY: ABBOTT PARK STATE: IL ZIP: 60064-6092 FORMER NAME: FORMER CONFORMED NAME: Funck Robert E DATE OF NAME CHANGE: 20130103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-05142024_090502.xml X0508 4 2024-05-10 0000001800 ABBOTT LABORATORIES ABT 0001565892 Funck, Jr. Robert E. 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 false true false false EXECUTIVE VICE PRESIDENT 0 Common shares without par value 2024-05-10 4 M 0 10097 47 A 221438 D Common shares without par value 2024-05-10 4 S 0 10097 104.5676 D 211341 D Common shares without par value 20000 I By Trust Common shares without par value 20000 I By Trust Common shares without par value 18765 I Profit Sharing Trust Common shares without par value 500 I By Daughter Option (right to buy) 47 2024-05-10 4 M 0 10097 0 D 2016-02-20 2025-02-19 Common Shares 10097 45000 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.55 to $104.62, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust. Balance in the Abbott Laboratories Stock Retirement Trust as of May 10, 2024. The reporting person disclaims beneficial ownership of all securities held by his daughter. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. /s/ Robert E. Funck, Jr. by Jessica H. Paik, Attorney-in-Fact 2024-05-14